Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
2.
Ann Burns Fire Disasters ; 35(2): 152-159, 2022 Jun 30.
Article in French | MEDLINE | ID: mdl-36381338

ABSTRACT

Armenia and Azerbaijan fought between September and November 2020 in Nagorno-Karabagh. Several surgical missions were scheduled by Assistance Publique- Hôpitaux de Paris to help care for the warinjured Armenians. These missions included the evaluation of Armenian soldiers suspected of having been injured by phosphorus. Facing, during these missions, such infrequent burns, we were interested in their pathophysiology, care and complications. Repeated up-to-date information is necessary in order to better take care of phosphorus burns. Therefore, we conducted a literature review, using PubMed and the Mesh Terms "phosphorus" and "burns", without setting any date limit. The review acknowledges that phosphorus burns are deep, tend to spread and may be the cause of systemic toxicity including hypocalcaemia, which can lead to heart rate disturbance and even death. In the acute phase, burns should be extensively washed with normal saline or water before a mechanical decontamination. One should not use oily dressings, given the liposolubility of phosphorus. Subsequently, one or many debridements are necessary before starting wound coverage, for which any kind of plastic surgery may be used. Phosphorus burns are infrequent but serious. They mainly occur in warfare and should be known by any caregiver acting in this context.

3.
Ann Chir Plast Esthet ; 67(5-6): 382-392, 2022 Nov.
Article in French | MEDLINE | ID: mdl-36058764

ABSTRACT

Gynecomastia is the most frequently breast lesion in males. 148 patients (mean age 24,7 years) operated in our department were reviewed with a mean follow-up of five years. Gynecomastia occurred most frequently during puberty (77,7 %), was bilateral (86,5%) and idiopathic (89,9%). The size of the enlargement was evaluated according to Simon's-classification based on breast-volume and skin-redundancy. 17 (11,5%) stage 1, 77 (52%) stage 2A, 32 (21,6%) stage 2B, 22 (14,9%) stage 3. Clinical examination and mammography determined the consistency of gynecomastia: adipose or firm. 4 different surgical managements were used: 17 (11,5%) subcutaneous mastectomies, 4 (2,7%) liposuctions, 110 (74,3%) liposuctions associated with subcutaneous mastectomy, 17 (11,5%) total mastectomy. All techniques gave good morphologic results. Nonetheless, the authors recommend the combination «liposuction and subcutaneous mastectomy¼, as this technique presents many advantages: small intraoperative blood loss, good skin redraping, short hospital stay, complete histologic examination of the material removed.


Subject(s)
Breast Neoplasms , Gynecomastia , Lipectomy , Mastectomy, Subcutaneous , Breast Neoplasms/surgery , Gynecomastia/diagnosis , Gynecomastia/surgery , Humans , Lipectomy/methods , Male , Mastectomy , Mastectomy, Subcutaneous/methods , Retrospective Studies
4.
Obes Surg ; 31(6): 2607-2613, 2021 06.
Article in English | MEDLINE | ID: mdl-33660152

ABSTRACT

PURPOSE: The combination of obesity and diabetes mellitus are well-known risk factors for cardiovascular complications and perioperative morbidity in metabolic surgery. The aim of this study was to evaluate effectivity and reliability of the cardiac assessment in patients with diabetes prior to bariatric surgery. SETTING: Private, university-affiliated teaching hospital, Switzerland MATERIAL AND METHODS: Retrospective analysis of prospectively collected data on results and consequences of cardiac assessments in 258 patients with obesity and diabetes scheduled for primary bariatric surgery at our institution between January 2010 and December 2018. RESULTS: Out of 258 patients, 246 (95.3%) received cardiac diagnostics: 173 (67.1%) underwent stress-rest myocardial perfusion scintigraphy (MPS), 15 (5.8%) patients had other cardiac imaging including cardiac catheterization, 58 (22.5%) patients had echocardiography and/or stress electrocardiography, and 12 (4.7%) patients received no cardiac evaluation. Subsequently, cardiac catheterization was performed in 28 patients (10.9%), and coronary heart disease was detected and treated in 15 subjects (5.8%). Of these 15 individuals, 5 (33.3%) patients had diffuse vascular sclerosis, 8 (53.3%) patients underwent coronary angioplasty and stenting, and 2 (13.3%) patients coronary artery bypass surgery. Bariatric surgery was performed without perioperative cardiovascular events in all 258 patients. CONCLUSION: Our data suggest that a detailed cardiac assessment is mandatory in bariatric patients with diabetes to identify those with yet unknown cardiovascular disease before performing bariatric surgery. We recommend carrying out myocardial perfusion scintigraphy as a reliable diagnostic tool in this vulnerable population. If not viable, stress echocardiography should be performed as a minimum.


Subject(s)
Diabetes Mellitus , Obesity, Morbid , Humans , Morbidity , Obesity, Morbid/surgery , Reproducibility of Results , Retrospective Studies , Risk Factors , Switzerland/epidemiology
5.
Hum Reprod Open ; 2020(1): hoz041, 2020.
Article in English | MEDLINE | ID: mdl-32072021

ABSTRACT

STUDY QUESTION: What is the prevalence of cannabis use and the perceptions of its impact on fertility among infertility patients? SUMMARY ANSWER: A total of 13% of infertility patients used cannabis within the last year, and current usage is associated with patient perceptions of negative effects of cannabis on fertility and pregnancy. WHAT IS KNOWN ALREADY: Cannabis use is increasing among the general population and pregnant women, particularly in places where cannabis use is legal despite having known and potential negative effects on fertility and pregnancy. STUDY DESIGN SIZE DURATION: A cross-sectional patient survey study was performed between July 2017 and September 2017. Patients attending a university-affiliated hospital-based fertility clinic (n = 290) were invited to complete a written survey. Inclusion criteria were limited to the ability to read English. There were no exclusion criteria. PARTICIPANTS/MATERIALS SETTING METHODS: Of the 290 patients approached, 270 (93%) agreed to participate. The questions covered demographics, cannabis usage, perceptions of the effect of cannabis on fertility and pregnancy, cessation of use due to infertility and personal history of disclosing cannabis use to healthcare providers (HCP). MAIN RESULTS AND THE ROLE OF CHANCE: The results showed that 13% of respondents disclosed use of cannabis in the past year (past year users) and 38% had not used cannabis in the past year but had previously used cannabis (>1 year users) while 49% had never used cannabis (never users). Baseline demographics were similar for the three groups, but across four measures of fertility and pregnancy health, past-year users perceived less of a negative effect compared to >1 year users, and never users (P values of 0.02, 0.03, 0.01, <0.001 for questions on pregnancy, offspring health, male fertility and female fertility, respectively). Of past year users, 72% said they had or would disclose use to their HCP, but only 9.4% reported that their HCP had actually instructed them to discontinue use. LIMITATIONS REASONS FOR CAUTION: Self-reported patient surveys are subject to reporting bias and may not reflect actual use and perceptions. WIDER IMPLICATIONS OF THE FINDINGS: This study suggests that cannabis use is common among infertility patients. Given the known negative impacts of cannabis on pregnancy, the authors would have expected informed infertility patients to cease cannabis use as part of their efforts to conceive. As the prevalence of cannabis use in the last year among infertility patients is similar to that in the general Canadian population, it is unclear whether the prevalence of cannabis use in the sample population merely reflects the average usage in society or, after taking into account those who reduced their usage to improve their fertility, is a factor contributing to infertility and thus prompting fertility referral. Given concern about the potential negative impact of cannabis use on fertility, and that only 9% of past year users had been instructed by an HCP to cease cannabis use, HCPs should consider the benefits of counselling about cannabis cessation for patients who are attempting to conceive. Future research should focus on analysing the effects of cannabis use on female fertility and determining whether a reduction in use among patients with infertility can improve conception rates. STUDY FUNDING/COMPETING INTERESTS: Michelle Shin, Clinical Research Associate, is supported by the University of Toronto GREI Fellowship Fund, which is sponsored by unrestricted research grants from EMD Serono, Merck Canada and Ferring Pharmaceuticals. The authors have no potential conflicts of interest to disclose.

6.
Clin Transl Oncol ; 22(8): 1272-1279, 2020 Aug.
Article in English | MEDLINE | ID: mdl-31863354

ABSTRACT

PURPOSE: There is a gap in knowledge regarding the impact of micrometastases (MIC) and isolated tumor cells (ITCs) found in the sentinel lymph nodes of patients with endometrial cancer. Here, we present a meta-analysis of the published literature on the rate of MIC and ITCs after lymphatic mapping and determine trends in postoperative management. METHODS: Literature search of Medline and PubMed was done using the terms: micrometastases, isolated tumor cells, endometrial cancer, and sentinel lymph node. Inclusion criteria were: English-language manuscripts, retrospectives, or prospective studies published between January 1999 and June 2019. We removed manuscripts on sentinel node mapping that did not specify information on micrometastases or isolated tumor cells, non-English-language articles, no data about oncologic outcomes, and articles limited to ten cases or less. RESULTS: A total of 45 manuscripts were reviewed, and 8 studies met inclusion criteria. We found that the total number of patients with MIC/ITCs was 286 (187 and 99, respectively). The 72% of patients detected with MIC/ITCs in sentinel nodes received adjuvant therapies. The MIC/ITCs group has a higher relative risk of recurrence of 1.34 (1.07, 1.67) than the negative group, even if the adjuvant therapy was given. CONCLUSION: We noted that there is an increased relative risk of recurrence in patients with low-volume metastases, even after receiving adjuvant therapy. Whether adjuvant therapy is indicated remains a topic of debate because there are other uterine factors implicated in the prognosis. Multi-institutional tumor registries may help shed light on this important question.


Subject(s)
Endometrial Neoplasms/pathology , Neoplasm Micrometastasis/pathology , Neoplasm Recurrence, Local , Sentinel Lymph Node Biopsy , Sentinel Lymph Node/pathology , Female , Humans , Prospective Studies , Retrospective Studies , Sentinel Lymph Node Biopsy/statistics & numerical data
7.
Oncogene ; 34(10): 1220-30, 2015 Mar 05.
Article in English | MEDLINE | ID: mdl-24662830

ABSTRACT

Hec1 (highly expressed in cancer 1) or Nek2 (NIMA-related kinase 2) is often overexpressed in cancers with poor prognosis. Both are critical mitotic regulators, and phosphorylation of Hec1 S165 by Nek2 is required for proper chromosome segregation. Therefore, inactivation of Hec1 and Nek2 by targeting their interaction with small molecules represents an ideal strategy for tackling these types of cancers. Here we showed that new derivatives of INH (inhibitor for Nek2 and Hec1 binding) bind to Hec1 at amino acids 394-408 on W395, L399 and K400 residues, effectively blocking Hec1 phosphorylation on S165 by Nek2, and killing cancer cells at the nanomolar range. Mechanistically, the D-box (destruction-box) region of Nek2 specifically binds to Hec1 at amino acids 408-422, immediately adjacent to the INH binding motif. Subsequent binding of Nek2 to INH-bound Hec1 triggered proteasome-mediated Nek2 degradation, whereas the Hec1 binding defective Nek2 mutant, Nek2 R361L, resisted INH-induced Nek2 degradation. This finding unveils a novel drug-action mechanism where the binding of INHs to Hec1 forms a virtual death-trap to trigger Nek2 degradation and eventually cell death. Furthermore, analysis of the gene expression profiles of breast cancer patient samples revealed that co-elevated expressions of Hec1 and Nek2 correlated with the shortest survival. Treatment of mice with this kind of tumor with INHs significantly suppressed tumor growth without obvious toxicity. Taken together, the new INH derivatives are suitable for translation into clinical application.


Subject(s)
Neoplasms/metabolism , Neoplasms/pathology , Nuclear Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Animals , Benzamides/chemistry , Benzamides/pharmacology , Binding Sites , Cell Line, Tumor , Cytoskeletal Proteins , Disease Models, Animal , Disease Progression , Gene Expression , Heterografts , Humans , Indoles , Inhibitory Concentration 50 , Mitosis/drug effects , Models, Molecular , Molecular Conformation , NIMA-Related Kinases , Neoplasms/genetics , Neoplasms/mortality , Nuclear Proteins/antagonists & inhibitors , Nuclear Proteins/chemistry , Nuclear Proteins/genetics , Phosphorylation/drug effects , Prognosis , Protein Binding/drug effects , Protein Serine-Threonine Kinases/chemistry , Protein Serine-Threonine Kinases/genetics , Proteolysis/drug effects , Thiazoles/chemistry , Thiazoles/pharmacology , Valerates
8.
Acta Clin Belg ; 66(2): 142-3, 2011.
Article in English | MEDLINE | ID: mdl-21630615

ABSTRACT

Vitamin K deficiency bleeding (VKDB) in infants still occurs despite worldwide use of prophylaxis. Clinical manifestations can be dramatic with over 50% of patients presenting with intracranial haemorrhage and a mortality rate of 20% in late vitamin K deficiency bleeding. Special attention should be given to infants with a high risk profile (preterm, breast feeding, cholestasis, malabsorption). A tentative diagnosis can be made observing quick normalisation of some easy-to-perform haemostatic parameters (PT, aPTT) after administration of vitamin K. Nowadays, VKDB can still be the first clinical sign of diseases causing malabsorption of fat-soluble vitamins. In this case report, VKDB led to the diagnosis of cystic fibrosis, the most common fatal autosomal recessive disease among Caucasian people.


Subject(s)
Blood Coagulation Factors/metabolism , Cystic Fibrosis , Enzyme Replacement Therapy , Vitamin K Deficiency Bleeding , Vitamin K , Age of Onset , Breast Feeding , Cystic Fibrosis/complications , Cystic Fibrosis/diagnosis , Cystic Fibrosis/drug therapy , Cystic Fibrosis/metabolism , Cystic Fibrosis/physiopathology , Drug Administration Routes , Exocrine Pancreatic Insufficiency/etiology , Exocrine Pancreatic Insufficiency/metabolism , Exocrine Pancreatic Insufficiency/physiopathology , Exocrine Pancreatic Insufficiency/therapy , Failure to Thrive/etiology , Failure to Thrive/metabolism , Failure to Thrive/therapy , Female , Humans , Infant , Liver Function Tests , Malabsorption Syndromes/etiology , Malabsorption Syndromes/metabolism , Malabsorption Syndromes/physiopathology , Malabsorption Syndromes/therapy , Risk Factors , Treatment Outcome , Vitamin K/administration & dosage , Vitamin K/metabolism , Vitamin K Deficiency Bleeding/drug therapy , Vitamin K Deficiency Bleeding/epidemiology , Vitamin K Deficiency Bleeding/etiology , Vitamin K Deficiency Bleeding/metabolism , Vitamin K Deficiency Bleeding/physiopathology , Vitamins/administration & dosage , Vitamins/metabolism
9.
Saudi J Kidney Dis Transpl ; 22(1): 112-5, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21196624

ABSTRACT

We report two cases of drug interaction between rifampicin and sirolimus in renal trans-plant patients who were diagnosed with tuberculosis after transplantation and induction of immuno-suppressive therapy with sirolimus. The dosage of sirolimus had to be increased, in one case up to six-fold and in the second case up to five-fold, to maintain serum levels after starting the rifampicin. The two patients tolerated the treatment well, with no signs of tuberculosis and good renal function.


Subject(s)
Antibiotics, Antitubercular/adverse effects , Immunosuppressive Agents/adverse effects , Kidney Transplantation , Rifampin/adverse effects , Sirolimus/adverse effects , Tuberculosis, Pulmonary/drug therapy , Adult , Drug Interactions , Humans , Immunosuppressive Agents/blood , Immunosuppressive Agents/pharmacokinetics , Male , Middle Aged , Sirolimus/blood , Sirolimus/pharmacokinetics , Tuberculosis, Pulmonary/diagnosis
10.
Pacing Clin Electrophysiol ; 29(11): 1312-4, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17100691

ABSTRACT

We report a case of recurrent postcardiac injury syndrome (PCIS) after pacemaker lead insertion. Each episode was attended by hemorrhagic pleuro-pericardial effusion with drop in hemoglobin levels leading us to consider cardiac perforation and subject the patient to surgical pericardiotomy. However, no perforation or active bleeding was detected on exploration. This unusual case illustrates the occurrence of PCIS following pacemaker lead insertion, mimicking cardiac perforation. This entity should be considered in patients who, after pacemaker lead insertion, develop pericardial and pleural effusion associated with markers of inflammation.


Subject(s)
Electrodes, Implanted/adverse effects , Heart Injuries/etiology , Pacemaker, Artificial/adverse effects , Pericardial Effusion/etiology , Pleural Effusion/etiology , Wounds, Penetrating/diagnosis , Wounds, Penetrating/etiology , Diagnosis, Differential , Female , Humans , Middle Aged , Recurrence , Syndrome
11.
Article in English | MEDLINE | ID: mdl-15123190

ABSTRACT

In prior studies in man, we have demonstrated that pressure-induced hyperemia lasts for prolonged periods as compared to the short-term hyperemia created by proximal arterial occlusion. We have analyzed this phenomenon in our well-studied rat model of skin blood flow. Skin blood flow was measured using laser Doppler techniques in Wistar Kyoto rats at the back, a nutritively perfused site, and at the plantar surface of the paw, where arteriovenous anastomotic perfusion dominates. A customized pressure feedback control device was used to vary applied pressures. At the back, pressures in excess of 80 mmHg resulted in occlusion, whereas at the paw 150 mmHg was required. The peak hyperemic flow after release of pressure was comparable to that elicited by proximal arterial occlusion with a blood pressure cuff. However, the post pressure hyperemia peak descended to a plateau value, which was 50-100% greater than baseline and continued for up to 20 min while the peak following proximal arterial occlusion returned to baseline within 4 min. At the back, post pressure hyperemia reached a maximum after application of 100 mmHg pressure. The application of higher pressures than required for occlusion produced no greater hyperemic response. At the paw, maximum post pressure hyperemia occurred at 100 mmHg, although this pressure level was not totally occlusive. Higher pressures resulted in no greater hyperemia. At the back, 10 min of occlusion produced a maximal peak value whereas 1 min was sufficient at the paw. The application of pressure to a heated probe with subsequent release, produced a hyperemic response. Normalized to baseline blood flow, there was no difference between the hyperemic responses at basal skin temperature and at 44 degrees C. There is a prolonged hyperemic response following local pressure occlusion compared to a much shorter period following proximal ischemic occlusion. One can presume two different mechanisms, one related to ischemia and the other a separate pressure related phenomenon. The thermal vasodilatory response is additive, not synergistic with the post pressure hyperemia we have demonstrated. This finding suggests that different mechanisms are involved in thermal vasodilation and post pressure hyperemia.


Subject(s)
Hyperemia/etiology , Pressure , Regional Blood Flow , Skin/blood supply , Animals , Arteries/physiopathology , Cerebrovascular Disorders/etiology , Extremities/blood supply , Hot Temperature , Rats , Rats, Inbred WKY , Temperature , Time Factors , Vasodilation
12.
Clin Endocrinol (Oxf) ; 36(6): 579-83, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1424183

ABSTRACT

OBJECTIVE: Severe selenium deficiency has been documented in northern Zaïre, already known as one of the most iodine deficient regions in the world and characterized by a predominance of the myxoedematous form of cretinism. This has been attributed to the double deficiency of essential trace elements. A short selenium supplementation programme was conducted in this area to evaluate the effects of a selenium supplementation on thyroid diseases. DESIGN: Placebo or selenium 50 micrograms as selenomethionine was administered once daily for 2 months. Blood and urine samples were collected before and after supplementation. PATIENTS: Fifty-two healthy schoolchildren from northern Zaire. MEASUREMENT: Selenium status, thyroid function and urinary iodide were determined. RESULTS: After 2 months of selenium supplementation, mean +/- SD serum T4 decreased from 73.1 +/- 45.4 to 48.3 +/- 23.7 nmol/l (P less than 0.001), serum FT4 from 11.8 +/- 6.7 to 8.4 +/- 4.1 pmol/l (P less than 0.01), and serum rT3 from 124 +/- 115 to 90 +/- 72 pmol/l (P less than 0.05), without significant change in serum T3 and serum TSH. CONCLUSION: Deiodinase type I which has been shown to be a seleno-enzyme could account for the changes in thyroid hormones in our subjects. Our data show that selenium plays a definite role in thyroid hormone metabolism in humans. Selenium could be an important cofactor in the clinical picture of iodine deficiency in Central Africa and could be involved in the aetiology of both forms of cretinism.


Subject(s)
Iodine/deficiency , Selenium/administration & dosage , Selenium/deficiency , Thyroid Hormones/blood , Administration, Oral , Humans , Iodine/administration & dosage , Selenium/blood , Thyroxine/blood , Triiodothyronine/blood , Triiodothyronine, Reverse/blood
13.
J Clin Endocrinol Metab ; 73(1): 213-5, 1991 Jul.
Article in English | MEDLINE | ID: mdl-2045471

ABSTRACT

Selenium and seleno dependent glutathione peroxidase (GPX) deficiency has been described in endemias of myxedematous cretinism. In northern Zaire, a selenium supplementation trial has been conducted. Beside correcting the GPX activity, two months of selenium supplementation was shown to modify the serum thyroid hormones parameters in clinically euthyroid subjects and to induce a dramatic fall of the already impaired thyroid function in clinically hypothyroid subjects. These results further support a role of selenium in thyroid hormone metabolism. In an iodine deficient area, this selenium deficiency could lead to opposite clinical consequences: protect the general population and the fetus against iodine deficiency and brain damage; and in turn, favour the degenerative process of the thyroid gland leading to myxoedematous cretinism.


Subject(s)
Hypothyroidism/drug therapy , Iodine/deficiency , Selenium/adverse effects , Child , Congenital Hypothyroidism/etiology , Democratic Republic of the Congo , Glutathione Peroxidase/metabolism , Humans , Hypothyroidism/etiology , Hypothyroidism/physiopathology , Selenium/deficiency , Selenium/therapeutic use , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood
14.
Med Trop (Mars) ; 46(1): 39-42, 1986.
Article in French | MEDLINE | ID: mdl-3702654

ABSTRACT

The following practical conclusions are based upon a study undertaken by the authors on a series of 138 strangulated groin hernias: the necessity of a basic medical education for rural population that will lead to treatment of hernias before complications as well as early treatment of complicated hernias; careful clinical examinations of the elderly patient in order to screen eventuel colic or rectal obstructions capable of creating symptomative strangulation; to adapt therapeutic attitude towards the location and extent of the lesion.


Subject(s)
Hernia, Inguinal/complications , Adult , Aged , Female , Hernia, Inguinal/diagnosis , Hernia, Inguinal/surgery , Humans , Male , Middle Aged , Patient Compliance , Patient Education as Topic , Rural Population
SELECTION OF CITATIONS
SEARCH DETAIL
...